Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T15:36:23.042Z.
Calculation as of: 2026-10-06T15:36:23.042Z.
Quote observation: 2026-10-06T15:34:58.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4140271b5ba2e17517ffa776ba39ee0784cb590c71b20d0313403f3757235181
EARNINGS YIELD
N/A
Market Cap
$1.15B
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.15B
Earnings Yield
1.28%
TTM Avg
2.76%
3Y Avg
2.15%
5Y Avg
2.02%
Market Cap
$1.21B
Earnings Yield
N/A
TTM Avg
1.54%
3Y Avg
1.54%
5Y Avg
1.54%
Market Cap
$1.13B
Earnings Yield
6.57%
TTM Avg
8.81%
3Y Avg
8.09%
5Y Avg
6.50%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.17B | N/A | N/A | N/A | N/A |
| Nektar Therapeutics (NKTR)vs › | $1.17B | N/A | 10.18% | 10.18% | 6.97% |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.15B | N/A | N/A | N/A | N/A |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.15B | 1.28% | 2.76% | 2.15% | 2.02% |
| OPKO Health, Inc. (OPK)vs › | $1.14B | N/A | 3.24% | 3.19% | 3.19% |
| Innovage Holding Corp. (INNV)vs › | $1.21B | N/A | 1.54% | 1.54% | 1.54% |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.13B | 6.57% | 8.81% | 8.09% | 6.50% |
| Harrow Health, Inc. (HROW)vs › | $1.13B | N/A | 2.62% | 13.63% | 13.63% |
| MannKind Corporation (MNKD)vs › | $1.22B | N/A | 1.85% | 1.41% | 1.41% |
| Omada Health (OMDA)vs › | $1.22B | 0.31% | 0.29% | 0.29% | 0.29% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
